INTERVIEW: I-SPY 2 investigator on cancer study, Synta's ganetespib

The investigator-sponsored I-SPY 2 clinical trial is an ambitious undertaking with a complicated protocol designed to generate data fairly quickly that can predict the chances of Phase III success for breast cancer therapies from various companies.